PFE

Pfizer Inc

Trading Strategies

Here's the Best Time to Buy AAPL and TSLA Stock

by

For the 56th time since 1896, the Dow Jones has spiced things up – Exxon Mobil, Pfizer, and Raytheon are out, and "new economy," biotech, and tech stocks Salesforce.com, Amgen, and Honeywell International are in.

But for sharp traders, the real story – and the real opportunity – is over on the high-flying NASDAQ Composite.

Sure, the endless string of new record highs is nice, but I'm talking about the stock splits approved by the boards of Apple and Tesla. AAPL and TSLA shares split 4-for-1 and 5-for-1, respectively.

That ignited monster rallies in both stocks and, in short order, long-term bulls will get a beautiful entry point.

The thing is, it's not right now.

I'm going to show you the signal to watch for to know exactly when to strike for profit… Full Story

I'm going to show you the signal to watch for to know exactly when to strike for profit...

Dow Jones

Why the Dow Jones Swapped Out Three Stocks Today

by

The Dow Jones Industrial Average executed a minor overhaul today.

As of the opening bell, three stocks were removed from the index and three new stocks added in their place.

Dow Jones said it took the action because of the impact of the Apple stock split – it didn't want the tech sector to have less influence.

But how will this affect the DJIA and its component stocks going forward?.

Here's everything you need to know...

Trading Strategies

Three Breakout Income Stocks to Grow Your Wealth for Years

by

Yields are up right now – and that's good news for investors who want to make some income.

With the stock market still down about 14% from its record highs in February, yields have climbed from an average 1.9% in February to 2.4% in April.

Of course, you don't have to settle for just yield.

You can buy stocks with healthy yield and that are climbing higher, so you can get paid to hold it and see your investment grow.

To find those stocks, our Chris Johnson turns to the technicals – otherwise known as the EKG of the market, showing you exactly what's going on.

Today, the technicals have led me to three breakout income stocks that are flashing the key bullish signals I look for when buying and that give you reliable yield...

Stocks

Markets Live Recap: Stocks Jump After Successful Treatment Trials

by

Investors got another vote of confidence today and bid stocks higher after Dr. Anthony Fauci expressed optimism about a potential coronavirus treatment from Gilead Sciences Inc. (NASDAQ: GILD).

Gilead's Remdesivir drug preliminary results showed at least 50% of patients treated with a five-day dosage improved.

The S&P 500 jumped 2.6%, putting the index on track for its best month since 1974.

At the same time, the curve does not appear to be flattening in the United States yet.

As of yesterday, over 1 million Americans have officially been diagnosed with the coronavirus.

And 32 million Americans are still officially unemployed.

That's approximately 19.5% of the 164.5 million total work force.

The stock market is clearly not representing the economy right now.

Instead, it's being propped up by the government.

Here's what our experts – Chris Johnson, Tom Gentile, and Shah Gilani – thought about today's positive move and where they see stocks moving forward.

Read more...

Biotechnology

Read This Before You Play a Single One of the Biotechs Fighting COVID-19

by

Georgia, South Carolina, and Florida have announced that they are loosening quarantine restrictions; at least 13 more states have announced plans or "roadmaps" to do more or less the same thing.

There's an urgent desire to get "back to normal" as quickly as possible because the social and economic devastation – record unemployment, more than 55,300 deaths, massive lockdowns, shrinking GDP, and of course the virus itself – of the coronavirus pandemic has been so profound.

And this has all happened in a little more than a month. People are understandably anxious to put all this behind them, myself very much included.

But the stakes of "normalcy" are higher than we're being told. The successful reemergence of people into the world will require far more than just repeated reminders to wash your hands and not touch your face.

Social distancing and limited interaction can slow the spread; there's mounting evidence in the United States and other countries that we've done precisely that. But it's far from clear how much those actions could really prevent widespread illness as lockdowns ease and stay-at-home orders are lifted.

Because it's very likely that we won't be truly "safe" until a proven treatment and effective vaccine are available.

The more we learn about this virus, the more we're aware of why its ongoing impact, and the "right" way to reopen the economy, remain so uncertain.

Here's what we do know… Full Story

Here's what we do know... Full Story